How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

A research team at Mohamed bin Zayed University of Artificial Intelligence published a finding in April 2026 that has gained traction in engineering circles for reasons that go beyond its headline ...

Attackers compromised the official Mistral AI Python package on PyPI along with hundreds of other widely-used developer packages, exposing GitHub tokens, cloud credentials, and password vaults across ...

First AI zero-day: Google uncovered the first known zero-day exploit developed using AI, capable of bypassing two-factor authentication on a widely used administration tool. Attack foiled: The flaw ...

While previous assessments categorized AI-assisted cyberattacks as experimental, current data suggests generative AI is now a mature, industrialized component of offensive operations.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Getting ready for coding interviews can feel like a big task, and figuring out the best way to tackle LeetCode is a common question. Many people find that using Python for their LeetCode solutions ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes roughly ...